Veraxa Biotech Holding-31VRXAWPreferred / convertible

13F holders, Q2 2026 (June 30)
26holders
$0.11avg. 13F price*

At the end of Q2 2026, 26 institutions reported holding Veraxa Biotech Holding-31 (VRXAW) in their 13F filings. The largest holders were CSS LLC ($177K), LMR Partners LLP ($120K) and Magnetar Financial LLC ($116K).

Company
Veraxa Biotech Holding-31
CUSIP
H9130A111
Latest filing quarter
Q2 2026

Total Exit/New Position Q2 2026

InstitutionsTotal Value
New Positions26$949K
Exits0$0

Ownership 26 holders

CSS LLC — New 1,600,882 $177K
LMR Partners LLP — New 1,089,100 $120K
Magnetar Financial LLC — New 1,055,078 $116K
Aristeia Capital, L.L.C. — New 976,083 $116K
Alberta Investment Management Corp — New 875,000 $97K
AQR Arbitrage LLC — New 658,138 $73K
Clear Street Group Inc. — New 485,358 $54K
BNP Paribas Financial Markets — New 253,207 $28K
Whitebox Advisors LLC — New 193,612 $21K
Wealthspring Capital LLC — New 185,330 $20K
Westchester Capital Management, LLC — New 183,647 $20K
TENOR CAPITAL MANAGEMENT Co., L.P. — New 150,000 $17K
Shaolin Capital Management LLC — New 142,083 $16K
MMCAP International Inc. SPC — New 125,000 $14K
Lineage Point Capital LP — New 102,749 $11K
Context Capital Management, LLC — New 100,000 $11K
Hudson Bay Capital Management LP — New 100,000 $11K
Yakira Capital Management, Inc. — New 98,360 $11K
Berkley W R Corp. — New 59,990 $7K
Verition Fund Management LLC — New 43,672 $5K
Schonfeld Strategic Advisors LLC — New 19,892 $2K
HRT Financial LP — New 25,573 $2K
Susquehanna International Group, LLP — New 10,267 $1K
Wolverine Asset Management LLC — New 2,917 $322
Longfellow Investment Management Co. LLC — New 194 $21
UBS Group AG — New 1 $0

"% of holder's portfolio" is VRXAW's weight in each manager's 13F, not the share of Veraxa Biotech Holding-31 the manager owns.